Hemin therapy improves kidney function in male streptozotocin-induced diabetic rats: Role of the heme oxygenase/atrial natriuretic peptide/adiponectin axis

Endocrinology

Volumn 155, Issue 1, 2014, Pages 215-229

  Ndisang, Joseph Fomusi ^a   Jadhav, Ashok ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ALDOSTERONE; ATRIAL NATRIURETIC FACTOR; CHROMIUM MESOPORPHYRIN; COLLAGEN TYPE 4; FIBRONECTIN; HEME OXYGENASE; HEMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESOPORPHYRIN; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 1 ALPHA; PROTEIN; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALBUMINURIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BODY WEIGHT; CELL VACUOLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DISEASE MARKER; DRUG EFFECT; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FLUID INTAKE; GLOMERULOSCLEROSIS; HEMIN THERAPY; HORMONAL THERAPY; HYPERGLYCEMIA; KIDNEY FUNCTION; KIDNEY TUBULE NECROSIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEINURIA; RAT; REAL TIME POLYMERASE CHAIN REACTION; SODIUM BLOOD LEVEL; SODIUM URINE LEVEL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SYSTOLIC BLOOD PRESSURE; URINE VOLUME;

EID: 84891457364     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2013-1050     Document Type: Article

References (61)

1. Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, Garcia-Perez J. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011;7:327-340.
2. Navarro-Gonzalez JF, Mora-Fernandez C. Inflammatory pathways. Contrib Nephrol. 2011;170:113-123.
3. Strawn WB. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes]. Drugs 62 Spec No. 2002;1:31-41.
4. Iwamoto M, Mizuiri S, Arita M, Hemmi H. Nuclear factor-αB activation in diabetic rat kidney: evidence for involvement of P-selectin in diabetic nephropathy. Tohoku J Exp Med. 2005;206:163-171.
5. Cifuentes M, Fuentes C, Tobar N, et al. Calcium sensing receptor activation elevates proinflammatory factor expression in human adipose cells and adipose tissue. Mol Cell Endocrinol. 2012;361: 24-30.
6. Ndisang JF. Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity. Mediators Inflamm. 2010;2010: 359732.
7. Gordon S, Martinez FO. Alternative activation of macrophages: mechanism and functions. Immunity. 2010;32:593-604.
8. Jadhav A, Torlakovic E, Ndisang JF. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol. 2009;296:F521-F534.
9. Mezzano S, Aros C, Droguett A, et al. NF-αB activation and overexpression of regulated genes in human diabetic nephropathy. Nephrol Dial Transplant. 2004;19:2505-2512.
10. Tiwari S, Ndisang JF. The heme oxygenase system and type 1 diabetes. Curr Pharm Des. [published online July 25, 2013
11. Tiwari S, Ndisang JF. Heme oxygenase system and hypertension: a comprehensive insight. Curr Pharm Des. [published online July 25, 2013
12. Mishra M, Ndisang JF. A critical and comprehensive insight on heme oxygenase and related products including carbon monoxide, bilirubin, biliverdin and ferritin in type-1 and type-2 diabetes. Curr Pharm Des. [published online July 25, 2013
13. Jadhav A, Ndisang JF. Treatment with heme arginate alleviates adipose tissue inflammation and improves insulin sensitivity and glucose metabolism in a rat model of human primary aldosteronism. Free Radic Biol Med. 2012;53:2277-2286.
14. Ndisang JF, Jadhav A. Up-regulating the hemeoxygenase system enhances insulin sensitivity and improves glucose metabolism in insulin-resistant diabetes in Goto-Kakizaki rats. Endocrinology. 2009;150:2627-2636.
15. Ndisang JF, Jadhav A. Heme oxygenase system enhances insulin sensitivity and glucose metabolism in streptozotocin-induced diabetes. Am J Physiol Endocrinol Metab. 2009;296:E829-E841.
16. Ndisang JF, Jadhav A. The heme oxygenase system attenuates pancreatic lesions and improves insulin sensitivity and glucose metabolism in deoxycorticosterone acetate hypertension. Am J Physiol Regul Integr Comp Physiol. 2010;298:R211-R223.
17. Ndisang JF, Lane N, Jadhav A. Upregulation of the heme oxygenase system ameliorates postprandial and fasting hyperglycemia in type 2 diabetes. Am J Physiol Endocrinol Metab. 2009;296:E1029-E1041.
18. Ndisang JF, Lane N, Syed N, Jadhav A. Up-regulating the heme oxygenase system with hemin improves insulin sensitivity and glucose metabolism in adult spontaneously hypertensive rats. Endocrinology. 2010;151:549-560.
19. Ndisang JF, Jadhav A.Hemearginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. J Pharmacol Exp Ther. 2010;334:87-98.
20. Ndisang JF. The heme oxygenase system selectively modulates proteins implicated in metabolism, oxidative stress and inflammation in spontaneously hypertensive rats. CurrPharmDes. [published online July 25, 2013
21. Moro C, Klimcakova E, Lolmede K, et al. Atrial natriuretic peptide inhibits the production of adipokines and cytokines linked to inflammation and insulin resistance in human subcutaneous adipose tissue. Diabetologia. 2007;50:1038-1047.
22. Folco EJ, RochaVZ,Lopez-IlasacaM,Libby P. Adiponectin Inhibits pro-inflammatory signaling in human macrophages independent of interleukin-10. J Biol Chem. 2009;284:25569-25575.
23. Piechota M, Banach M, Irzmanski R, et al. N-terminal brain natriuretic propeptide levels correlate with procalcitonin and C-reactive protein levels in septic patients. Cell Mol Biol Lett. 2007;12:162-175.
24. Li X, Meng Y, Wu P, Zhang Z, Yang X. Angiotensin II and aldosterone stimulating NF-αB and AP-1 activation in hepatic fibrosis of rat. Regul Pept. 2007;138:15-25.
25. Ding W, Yang L, Zhang M, Gu Y. Chronic inhibition of nuclear factor B attenuates aldosterone/salt-induced renal injury. Life Sci. 2012;90:600-606.
26. WuYP, Proia RL. Deletion of macrophage-inflammatory protein 1-retards neurodegeneration in Sandhoff disease mice. Proc Natl Acad Sci USA. 2004;101:8425-8430.
27. Ndisang JF, Lane N, Jadhav A. The heme oxygenase system abates hyperglycemia in Zucker diabetic fatty rats by potentiating insulinsensitizing pathways. Endocrinology. 2009;150:2098-2108.
28. Jadhav A, Torlakovic E, Ndisang JF. Interaction among heme oxygenase, nuclear factor-αB, and transcription activating factors in cardiac hypertrophy in hypertension. Hypertension. 2008;52:910-917.
29. Ndisang JF, Lane N, Jadhav A. Crosstalk between the heme oxygenase system, aldosterone, and phospholipase C in hypertension. J Hypertens. 2008;26:1188-1199.
30. Ndisang JF, Jadhav A. Hemin therapy suppresses inflammation and retroperitoneal adipocyte hypertrophy to improve glucose metabolism in obese rats co-morbid with insulin resistant type 2 diabetes. Diabetes Obes Metab. 2013;15(11):1029-1039.
31. Ndisang JF, Mishra M. The heme oxygenase system selectively suppresses the proinflammatory macrophage m1 phenotype and potentiates insulin signaling in spontaneously hypertensive rats. Am J Hypertens. 2013;26:1123-1131.
32. Turkseven S, Kruger A, Mingone CJ, et al. Antioxidant mechanism of heme oxygenase-1 involves an increase in superoxide dismutase and catalase in experimental diabetes. Am J Physiol Heart Circ Physiol. 2005;289:H701-H707.
33. Vreman HJ, Ekstrand BC, Stevenson DK. Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res. 1993;33:195-200.
34. Jadhav A, Ndisang JF. Heme arginate suppresses cardiac lesions and hypertrophy in deoxycorticosterone acetate-salt hypertension. Exp Biol Med (Maywood). 2009;234:764-778.
35. Jadhav A, Tiwari S, Lee P, Ndisang JF. The heme oxygenase system selectively enhances the anti-inflammatory macrophage-m2 phenotype, reduces pericardial adiposity, and ameliorated cardiac injury in diabetic cardiomyopathy in Zucker diabetic fatty rats. J Pharmacol Exp Ther. 2013;345:239-249.
36. Matavelli LC, Siragy HM. Reduction of aldosterone production improves renal oxidative stress and fibrosis in diabetic rats. J Cardiovasc Pharmacol. 2013;61(1):17-22.
37. Shoham S, Bejar C, Kovalev E, Weinstock M. Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats. Exp Neurol. 2003; 184:1043-1052.
38. Chen NY, Chen WY, Bellush L, et al. Effects of streptozotocin treatment in growth hormone (GH) and GH antagonist transgenic mice. Endocrinology. 1995;136:660-667.
39. Pandey KN. Biology of natriuretic peptides and their receptors. Peptides. 2005;26:901-932.
40. Ndisang JF, Jadhav A. Heme-Arginate suppresses phospholipase C and oxidative stress in the mesenteric arterioles of mineralcorticoidinduced hypertensive rats. Hypertens Res. 2010;33:338-347.
41. Benigni A, Zoja C, Zatelli C, et al. Vasopeptidase inhibitor restores the balance of vasoactive hormones in progressive nephropathy. Kidney Int. 2004;66:1959-1965.
42. Burgess A, Li M, Vanella L, et al. Adipocyte heme oxygenase-1 induction attenuates metabolic syndrome in both male and female obese mice. Hypertension. 2010;56:1124-1130.
43. Sharma K, Ramachandrarao S, Qiu G, et al. Adiponectin regulates albuminuria and podocyte function in mice. J Clin Invest. 2008; 118:1645-1656.
44. Yamauchi T, Kamon J, Minokoshi Y, et al. Adiponectin stimulates glucose utilization and fatty-Acid oxidation by activating AMP-Activated protein kinase. Nat Med. 2002;8:1288-1295.
45. DiPetrillo K, Coutermarsh B, Soucy N, Hwa J, Gesek F. Tumor necrosis factor induces sodium retention in diabetic rats through sequential effects on distal tubule cells. Kidney Int. 2004;65:1676-1683.
46. Yang J, Pollock JS, Carmines PK. NADPH oxidase and PKC contribute to increased Na transport by the thick ascending limb during type 1 diabetes. Hypertension. 2012;59:431-436.
47. Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol. 2011;11:750-761.
48. Gordon S. Alternative activation of macrophages. Nat Rev Immunol. 2003;3:23-35.
49. Aki K, Shimizu A, Masuda Y, et al. ANG II receptor blockade enhances anti-inflammatory macrophages in anti-glomerular basement membrane glomerulonephritis. Am J Physiol Renal Physiol. 2010;298:F870-F882.
50. Satoh-Asahara N, Shimatsu A, Sasaki Y, et al. Highly purified eicosapentaenoic acid increases interleukin-10 levels of peripheral blood monocytes in obese patients with dyslipidemia. Diabetes Care. 2012;35:2631-2639.
51. Chatterjee PK, Hawksworth GM, McLay JS. Cytokine-stimulated nitric oxide production in the human renal proximal tubule and its modulation by natriuretic peptides: a novel immunomodulatory mechanism? Exp Nephrol. 1999;7:438-448.
52. Bertolani C, Marra F. Role of adipocytokines in hepatic fibrosis. Curr Pharm Des. 2010;16:1929-1940.
53. Finer G, SchnaperHW,Kanwar YS, Liang X, Lin HY, Hayashida T. Divergent roles of Smad3 and PI3-kinase in murine adriamycin nephropathy indicate distinct mechanisms of proteinuria and fibrogenesis. Kidney Int. 2012;82:525-536.
54. Tiwari S, Ndisang JF. The role of obesity in cardiomyopathy and nephropathy. Curr Pharm Des. [published online July 25, 2013
55. Lee MJ, Feliers D, Mariappan MM, et al. A role for AMP-Activated protein kinase in diabetes-induced renal hypertrophy. Am J Physiol Renal Physiol. 2007;292:F617-F627.
56. Birkenfeld AL, Boschmann M, Engeli S, et al. Atrial natriuretic peptide and adiponectin interactions in man. PLoS One. 2012;7: e43238.
57. Kiemer AK, Bildner N, Weber NC, Vollmar AM. Characterization of heme oxygenase 1 (heat shock protein 32) induction by atrial natriuretic peptide in human endothelial cells. Endocrinology. 2003;144:802-812.
58. Polte T, Hemmerle A, Berndt G, Grosser N, Abate A, Schroder H. Atrial natriuretic peptide reduces cyclosporin toxicity in renal cells: role of cGMP and heme oxygenase-1. Free Radic Biol Med. 2002; 32:56-63.
59. Sechi LA, Valentin JP, Griffin CA, et al. Receptors for atrial natriuretic peptide are decreased in the kidney of rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1995;95:2451-2457.
60. Patel KP. Volume reflex in diabetes. Cardiovasc Res. 1997;34: 81-90.
61. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-e146.